Learn more

VIVENTIA BIOTECH INC

Overview
  • Total Patents
    58
About

VIVENTIA BIOTECH INC has a total of 58 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Canada, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are EPSTEIN ALAN L, ONCOMATRYX BIOPHARMA S L and KOLLTAN PHARMACEUTICALS INC.

Patent filings per year

Chart showing VIVENTIA BIOTECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cizeau Jeannick 29
#2 Chahal Francina C 22
#3 Macdonald Glen 17
#4 Dan Michael D 10
#5 Maiti Pradip K 9
#6 Entwistle Joycelyn 9
#7 Kaplan Howard A 8
#8 Glover Nicholas R 7
#9 Bosc Denis Georges 6
#10 Macdonald Glen Christopher 6

Latest patents

Publication Filing date Title
WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof
CN101970498A Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof
WO2009039630A1 Optimized nucleic acid sequences for the expression of vb4-845
WO2008128329A1 Endotoxin removal
WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
WO2008052322A1 Immunotoxγn fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers
CA2633138A1 Methods for generating and screening fusion protein libraries and uses thereof
NZ569450A An isolated protein comprising a cancer-associated variant of Mammalian Scratch
WO2007051315A1 Methods and processes of controlling fermentation
WO2006105653A1 Method and system for identification of antigen
CN101160402A Cancer specific antibody and cell surface proteins
AU7243200A Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
CA2384388A1 Enhanced phage display library of human vh fragments and methods for producing same
NZ505305A Antigen binding fragments that inhibit an antibody comprising amino acid sequences of H and L chain V regions of a scFv from binding to the surface of a cancer cell
US7115722B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
EP0766736A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen